Notícias e Atividades da BioNano Genomics
Presença
Sede: Estados Unidos
BioNano Genomics é uma empresa listada sob o símbolo BNGO (US).
Executivos
Veja o organograma con seus 21 executivos principais
Biografias mais buscadas da BioNano Genomics
- Albert Luderer, Interim Chief Executive Officer and Chairman of th...
- David Barker, Director
- Kristiina Vuori, Director
Recentes movimentos de executivos em BioNano Genomics
- Alka Chaubey, Chief Medical Officer, deixou a Companhia (Notícia publicada em 6 de julho de 2026).
- Alex Hastie, ingressou na Companhia como Chief Scientific Officer (Notícia publicada em 25 de junho de 2026).
- Christopher Twomey antes Director, agora é Lead Independent Director (Notícia publicada em 8 de maio de 2026).
Clique aqui para ver outras movimentos em BioNano Genomics
Criar um alerta
para seguir os movimentos de executivos da BioNano Genomics.
Biotecnologia
BioNano Genomics possui 2.428 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).
Popular M&A news in Biotecnologia
- Eli Lilly has announced the acquisition of AtaiBeckley (publicado em 17 de julho de 2026).
- GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
- Clearside Biomedical has gone out of its bankruptcy protection (publicado em 15 de julho de 2026).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de BioNano Genomics
- Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting | Bionano Genomics, Inc.
- Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress | Bionano Genomics, Inc.
- Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting | Bionano Genomics, Inc.
- Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 | Bionano Genomics, Inc.
- Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow’s Performance and Ability to Detect More SVs than LRS at Lower Cost | Bionano Genomics, Inc.
- Bionano to Present at the 2023 Stifel Healthcare Conference | Bionano Genomics, Inc.
- Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease | Bionano Genomics, Inc.
- Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia | Bionano Genomics, Inc.
- Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development | Bionano Genomics, Inc.
- Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health | Bionano Genomics, Inc.
- View more press releases Close
Redes sociais sobre BioNano Genomics
- BioNano Genomics na Wikipedia, Google News e Yahoo Finance
- BioNano Genomics na LinkedIn, X (Twitter) e YouTube
